These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4]. Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515 [TBL] [Abstract][Full Text] [Related]
8. [Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum]. Podgornaia LG; Dziuban NF Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):67-9. PubMed ID: 3092510 [TBL] [Abstract][Full Text] [Related]
9. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa. Gościniak G; Grzybek-Hryncewicz K Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177 [TBL] [Abstract][Full Text] [Related]
11. [An antigenic analysis and the protective properties of the R-form lipopolysaccharides of gram-negative bacteria]. Stanislavskiĭ ES; Makarenko TA; Kholodkova EV; Lugowski C Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):52-6. PubMed ID: 9783402 [TBL] [Abstract][Full Text] [Related]
12. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa]. Iushkova NA; Stanislavskiĭ ES; Landsman NM Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564 [TBL] [Abstract][Full Text] [Related]
13. [Antigenic composition and the serological diagnosis of Pseudomonas pseudomallei]. Kovalev GK Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):109-17. PubMed ID: 2412369 [No Abstract] [Full Text] [Related]
14. [Pseudomonas aeruginosa vaccine on the basis of antigens isolated from the supernatant of culture media K-4]. Nuriddinova NR; Ivanova LE; Sheremet'ev NN; Garib FIu Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):40-3. PubMed ID: 12449697 [TBL] [Abstract][Full Text] [Related]
15. [Immunochemical analysis and protective properties of components of Pseudomonas aeruginosa mucus with different molecular weights]. Zaĭdner IG; Palkina NA; Stanislavskiĭ ES; Landsman NM Zh Mikrobiol Epidemiol Immunobiol; 1981 Apr; (4):92-7. PubMed ID: 6791415 [TBL] [Abstract][Full Text] [Related]
16. Polysaccharide antigens of Pseudomonas aeruginosa. Knirel YA Crit Rev Microbiol; 1990; 17(4):273-304. PubMed ID: 1698385 [TBL] [Abstract][Full Text] [Related]
17. [Cell-free Pseudomonas vaccine. III. Immunochemical analysis of purified Pseudomonas aeruginosa protein antigens and protective properties of antisera against these antigens]. Chekan LV; Stanislavskiĭ ES; Polkina NA Zh Mikrobiol Epidemiol Immunobiol; 1983 Feb; (2):92-6. PubMed ID: 6188300 [TBL] [Abstract][Full Text] [Related]
18. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa. Hatano K; Boisot S; DesJardins D; Wright DC; Brisker J; Pier GB Infect Immun; 1994 Sep; 62(9):3608-16. PubMed ID: 7520416 [TBL] [Abstract][Full Text] [Related]
19. [Cell-free Pseudomonas vaccine. II. Isolation and immunological properties of protective antigens of Pseudomonas aeruginosa]. Stanislavskiĭ ES; Palkina NA; Bulk VF; Zhvanetskaia MI; Chekan LV Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):37-40. PubMed ID: 6797158 [No Abstract] [Full Text] [Related]